Cellectis (ALCLS) — Cash Flow Reinvestment Rate
Latest as of June 2024:
2.06x
Cellectis (ALCLS) has a Cash Flow Reinvestment Rate of 2.06x as of June 2024, reinvesting €107.47 Million (capex €1.04 Million plus investments €-106.43 Million) from operating cash flow of €52.18 Million. Explore how much does Cellectis reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
2.06x
(Capex + Investments) / Operating CF
Total Reinvested
€107.47 Million
Capex + Investments
Operating Cash Flow
€52.18 Million
EUR
Capital Expenditures
€1.04 Million
EUR
Cellectis Cash Flow Reinvestment Rate (2005–2024)
Historical reinvestment intensity for Cellectis across 5 annual periods. Also explore ALCLS total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cellectis (2005–2024)
Year-by-year capital reinvestment analysis for Cellectis. For live market cap and broader valuation context, see ALCLS market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.64x | €106.65 Million | €22.99 Million | €3.84 Million | ▲ +263.4% |
| 2015 | 1.28x | €4.52 Million | €3.54 Million | €4.25 Million | ▲ +3184.1% |
| 2014 | 0.04x | €1.97 Million | €50.74 Million | €430.47K | ▼ -91.3% |
| 2008 | 0.44x | €790.71K | €1.78 Million | €790.71K | ▼ -50.8% |
| 2005 | 0.90x | €353.00K | €391.00K | €353.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow